Atherectomy and Thrombectomy Devices Market Size, Share, Trends, Growth Outlook

Atherectomy and Thrombectomy Devices Market is estimated to increase at a growth rate of 6.6% CAGR over the forecast period from 2024 to 2030.

The Atherectomy and Thrombectomy Devices Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Atherectomy Devices, Thrombectomy Devices), By End-User (Hospitals, Ambulatory Surgical Centers, Research Laboratories and Academic Institutes).

An Introduction to Atherectomy and Thrombectomy Devices Market in 2024

The Atherectomy and Thrombectomy Devices Market in 2024 is experiencing steady growth, driven by the increasing prevalence of peripheral artery disease (PAD), rising demand for minimally invasive vascular interventions, and advancements in atherectomy and thrombectomy technologies to improve procedural efficacy, reduce complications, and enhance patient outcomes in patients with occlusive arterial lesions and thrombotic disorders. PAD represents a common vascular condition characterized by the narrowing or blockage of arteries outside the heart, leading to reduced blood flow to the limbs and increased risk of cardiovascular events, necessitating effective endovascular treatments to restore arterial patency and alleviate symptoms. With advancements in catheter-based devices, laser ablation systems, and mechanical thrombectomy technologies, the market offers a variety of atherectomy and thrombectomy devices, including rotational atherectomy systems, directional atherectomy devices, and aspiration thrombectomy catheters, tailored to specific lesion characteristics, procedural requirements, and operator preferences. Moreover, the integration of imaging guidance, adjunctive therapies, and vascular access techniques further enhances procedural success rates, limb salvage outcomes, and patient satisfaction in the management of PAD and thromboembolic disorders, driving market expansion and supporting the adoption of minimally invasive approaches to vascular intervention globally.

Atherectomy and Thrombectomy Devices Market Trend: Shift Towards Minimally Invasive Procedures

A prominent trend in the Atherectomy and Thrombectomy Devices market is the increasing adoption of minimally invasive procedures for the treatment of arterial diseases such as peripheral artery disease (PAD) and coronary artery disease (CAD). Minimally invasive techniques, including atherectomy and thrombectomy, offer advantages such as reduced patient recovery time, shorter hospital stays, and lower risk of complications compared to traditional open surgeries. As a result, there is a growing demand for advanced atherectomy and thrombectomy devices that enable physicians to effectively remove atherosclerotic plaque and thrombus from blood vessels while preserving vessel integrity.

Atherectomy and Thrombectomy Devices Market Driver: Rising Incidence of Cardiovascular Diseases

A key driver in the Atherectomy and Thrombectomy Devices market is the rising incidence of cardiovascular diseases (CVDs) worldwide. Conditions such as peripheral artery disease (PAD), coronary artery disease (CAD), and acute myocardial infarction (AMI) contribute significantly to morbidity and mortality globally. The increasing prevalence of risk factors such as obesity, hypertension, diabetes, and smoking, coupled with aging populations, is fueling the prevalence of CVDs. Atherectomy and thrombectomy devices play a crucial role in the management of these conditions by removing plaque and thrombus from blood vessels, restoring blood flow, and reducing the risk of cardiovascular events, driving the demand for these devices.

Atherectomy and Thrombectomy Devices Market Opportunity: Technological Innovations for Enhanced Efficacy and Safety

An opportunity for market growth in the Atherectomy and Thrombectomy Devices market lies in technological innovations aimed at enhancing the efficacy and safety of these devices. Advancements in device design, materials, and technology can lead to improved procedural outcomes, reduced procedure times, and lower complication rates. Opportunities exist for the development of next-generation atherectomy and thrombectomy devices with features such as improved navigation capabilities, enhanced visualization systems, and integrated real-time monitoring functionalities. Investing in research and development to innovate and refine atherectomy and thrombectomy devices can position companies to address the evolving needs of physicians and patients in the treatment of arterial diseases, ultimately driving market growth and competitiveness.

Atherectomy and Thrombectomy Devices Market Segmentation

By Product
Atherectomy Devices
Thrombectomy Devices
By End User
Hospitals
Ambulatory Surgical Centers
Research Laboratories and Academic Institutes
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Atherectomy and Thrombectomy Devices Market Companies

Argon Medical Devices
Bayer AG
Boston Scientific Corp
Cardiovascular Systems Inc
Covidien PLC
Getinge AB
Sorin Group USA Inc
Spectranetics Corp
Spectranetics Corp
St. Jude Medical Inc
Straub Medical AG
Terumo Medical Corp
Uscom Ltd
Vascular Solutions Inc
Ventracor Ltd
Zoll Medical Corp

 

 

Reasons to Buy the Atherectomy and Thrombectomy Devices Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Atherectomy and Thrombectomy Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Atherectomy and Thrombectomy Devices Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Atherectomy and Thrombectomy Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Atherectomy and Thrombectomy Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Atherectomy and Thrombectomy Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Atherectomy and Thrombectomy Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Atherectomy and Thrombectomy Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Atherectomy and Thrombectomy Devices Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Atherectomy and Thrombectomy Devices Market Industry
4.2 Key Market Trends in Atherectomy and Thrombectomy Devices Market Industry
4.3 Potential Opportunities in Atherectomy and Thrombectomy Devices Market Industry
4.4 Key Challenges in Atherectomy and Thrombectomy Devices Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Atherectomy and Thrombectomy Devices Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Atherectomy and Thrombectomy Devices Market Outlook By Segments
7.1 Atherectomy and Thrombectomy Devices Market Outlook by Segments
By Product
Atherectomy Devices
Thrombectomy Devices
By End User
Hospitals
Ambulatory Surgical Centers
Research Laboratories and Academic Institutes

8 North America Atherectomy and Thrombectomy Devices Market Analysis And Outlook To 2030
8.1 Introduction to North America Atherectomy and Thrombectomy Devices Markets in 2024
8.2 North America Atherectomy and Thrombectomy Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Atherectomy and Thrombectomy Devices Market size Outlook by Segments, 2021-2030
By Product
Atherectomy Devices
Thrombectomy Devices
By End User
Hospitals
Ambulatory Surgical Centers
Research Laboratories and Academic Institutes

9 Europe Atherectomy and Thrombectomy Devices Market Analysis And Outlook To 2030
9.1 Introduction to Europe Atherectomy and Thrombectomy Devices Markets in 2024
9.2 Europe Atherectomy and Thrombectomy Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Atherectomy and Thrombectomy Devices Market Size Outlook By Segments, 2021-2030
By Product
Atherectomy Devices
Thrombectomy Devices
By End User
Hospitals
Ambulatory Surgical Centers
Research Laboratories and Academic Institutes

10 Asia Pacific Atherectomy and Thrombectomy Devices Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Atherectomy and Thrombectomy Devices Markets in 2024
10.2 Asia Pacific Atherectomy and Thrombectomy Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Atherectomy and Thrombectomy Devices Market size Outlook by Segments, 2021-2030
By Product
Atherectomy Devices
Thrombectomy Devices
By End User
Hospitals
Ambulatory Surgical Centers
Research Laboratories and Academic Institutes

11 South America Atherectomy and Thrombectomy Devices Market Analysis And Outlook To 2030
11.1 Introduction to South America Atherectomy and Thrombectomy Devices Markets in 2024
11.2 South America Atherectomy and Thrombectomy Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Atherectomy and Thrombectomy Devices Market size Outlook by Segments, 2021-2030
By Product
Atherectomy Devices
Thrombectomy Devices
By End User
Hospitals
Ambulatory Surgical Centers
Research Laboratories and Academic Institutes

12 Middle East And Africa Atherectomy and Thrombectomy Devices Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Atherectomy and Thrombectomy Devices Markets in 2024
12.2 Middle East and Africa Atherectomy and Thrombectomy Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Atherectomy and Thrombectomy Devices Market size Outlook by Segments, 2021-2030
By Product
Atherectomy Devices
Thrombectomy Devices
By End User
Hospitals
Ambulatory Surgical Centers
Research Laboratories and Academic Institutes

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Argon Medical Devices
Bayer AG
Boston Scientific Corp
Cardiovascular Systems Inc
Covidien PLC
Getinge AB
Sorin Group USA Inc
Spectranetics Corp
Spectranetics Corp
St. Jude Medical Inc
Straub Medical AG
Terumo Medical Corp
Uscom Ltd
Vascular Solutions Inc
Ventracor Ltd
Zoll Medical Corp

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Atherectomy Devices
Thrombectomy Devices
By End User
Hospitals
Ambulatory Surgical Centers
Research Laboratories and Academic Institutes